Spironolactone and alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.

Metolactone 2.5 mg/50 mg Tablet may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Metolactone 2.5 mg/50 mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.

Do not drive unless you are feeling well.As Metolactone 2.5 mg/50 mg Tablet may cause drowsiness, dizziness, blurred vision, or lightheadedness and this may affect your ability to drive.

Metolactone 2.5 mg/50 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metolactone 2.5 mg/50 mg Tablet may be needed. Please consult your doctor.Use of Metolactone 2.5 mg/50 mg Tablet is not recommended in patients with severe kidney disease.

There is limited information available on the use of Metolactone 2.5 mg/50 mg Tablet in patients with liver disease. Please consult your doctor.